Zobrazeno 1 - 10
of 642
pro vyhledávání: '"Olshanskaya A"'
Autor:
Albert Itov, Karina Ilyasova, Olga Soldatkina, Anna Kazakova, Vladimir Kozeev, Alexandra Semchenkova, Elena Osipova, Elmira Boichenko, Egor Volchkov, Alexander Popov, Elena Zerkalenkova, Julia Roumiantseva, Galina Novichkova, Alexander Karachunskiy, Yulia Olshanskaya
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 1010-1013 (2024)
Abstract Pediatric low‐hypodiploidy B‐cell acute lymphoblastic leukemia (LH‐ALL) with TP53 variants has been proposed to be considered a manifestation of Li‐Fraumeni syndrome (LFS). However, our study demonstrates that of the majority the pat
Externí odkaz:
https://doaj.org/article/34844ff25b744e38bb67386eee37ff5d
Autor:
Dinara YESSIMOVA, Alina FAURAT, Alexandr BELYY, Ayana YESSIM, Aleksandra NOVIKOVA, Marina OLSHANSKAYA, Ruslan SAFAROV, Bahadur BILALOV, Silviu-Vasile BUMBAK
Publikováno v:
Geo Journal of Tourism and Geosites, Vol 54, Iss 2 supplement, Pp 967-976 (2024)
Prior to the integration of sustainable development principles into the tourism industry of Pavlodar region, it is essential to assess the current situation and the readiness of the sector participants to implement them. This requires exploring int
Externí odkaz:
https://doaj.org/article/1646f17ec59c44439a005a956eb15431
Autor:
I. Tsimafeyeu, P. Makhov, D. Ovcharenko, J. Smith, Y. Khochenkova, A. Olshanskaya, D. Khochenkov
Publikováno v:
Immuno-Oncology and Technology, Vol 23, Iss , Pp 100725- (2024)
Background: Fibroblast growth factor receptor 1 (FGFR1) plays a crucial role in carcinogenesis. Exploring the combination of the novel humanized monoclonal anti-FGFR1 antibody OM-RCA-01 and immunotherapy was intriguing due to involvement of FGFR1 in
Externí odkaz:
https://doaj.org/article/43c022b902de482aa5ac5965b28157dd
Autor:
Maria I. Volkova, Alexey S. Kalpinskiy, Olesya A. Goncharova, Konstantin V. Menshikov, Elena V. Karabina, Aleksand S. Dergunov, Natalya I. Polshina, Elena N. Alexandrova, Andrey A. Lebedinets, Alexey К. Panov, Alexander V. Sultanbaev, Evgeny A. Usynin, Mikhail V. Volkonskiy, Viktorya V. Mikhalyuk, Ruslan A. Zukov, Yulia V. Anzhiganova, Magomed A. Gusniev, Elena N. Igumnova, Svetlana V. Kuzmicheva, Ilya A. Pokataev, Anna S. Olshanskaya, Natalia I. Pervakova, Elvira L. Parsadanova, Tatyana A. Sannikova, Alexandr A. Bystrov, Daria M. Dubovichenko, Mukhitova R. Miliausha, Viacheslav A. Chubenko, Konstantin A. Shkret, Mariya N. Gorshenina, Mavzhuda К. Davlatova, Alina E. Kosareva, Olga A. Lutoshkina, Oxana A. Maslova, Maria V. Makhnutina, Anna V. Mishina, Makhabbat Zh. Murzalina, Oksana A. Podyacheva, Sergey A. Kalinin, Ovsep A. Mailyan, Alfiya R. Safarova, Ksenia O. Semenova, Mariya A. Strokova, Ekaterina Yu. Urashkina, Olesya S. Shmygina
Publikováno v:
Современная онкология, Vol 26, Iss 1, Pp 39-47 (2024)
Aim To evaluate the safety and toxicity of lenvatinib with pembrolizumab in unselected patients with advanced renal cell carcinoma (RCC). Materials and methods. The Russian phase IV observational study included 151 patients with advanced RCC who r
Externí odkaz:
https://doaj.org/article/b8f04fb084054d4fa93d3b87907a155b
Autor:
Tsimafeyeu, I., Makhov, P., Ovcharenko, D., Smith, J., Khochenkova, Y., Olshanskaya, A., Khochenkov, D.
Publikováno v:
In Immuno-Oncology and Technology September 2024 23
Autor:
Alexander Popov, Guenter Henze, Grigory Tsaur, Oleg Budanov, Julia Roumiantseva, Mikhail Belevtsev, Tatiana Verzhbitskaya, Liudmila Movchan, Svetlana Lagoyko, Liudmila Zharikova, Yulia Olshanskaya, Tatiana Riger, Alena Valochnik, Natalia Miakova, Dmitry Litvinov, Olga Khlebnikova, Olga Streneva, Elena Stolyarova, Natalia Ponomareva, Galina Novichkova, Olga Aleinikova, Larisa Fechina, Alexander Karachunskiy
Publikováno v:
Cancer Medicine, Vol 13, Iss 8, Pp n/a-n/a (2024)
Abstract Background Quantitative measurement of minimal residual disease (MRD) is the “gold standard” for estimating the response to therapy in childhood B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL). Nevertheless, the speed of the
Externí odkaz:
https://doaj.org/article/c4c2656517d94dbf8dad00592e9fda64
Autor:
E. V. Volchkov, A. A. Khozyainova, M. Kh. Gurzhikhanova, I. V. Larionova, V. E. Matveev, D. A. Evseev, A. K. Ignatova, M. E. Menyailo, D. A. Venyov, R. S. Vorobev, A. A. Semchenkova, Yu. V. Olshanskaya, E. V. Denisov, M. A. Maschan
Publikováno v:
npj Systems Biology and Applications, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Juvenile myelomonocytic leukemia (JMML) is a rare myeloproliferative disease of early childhood that develops due to mutations in the genes of the RAS-signaling pathway. Next-generation high throughput sequencing (NGS) enables identification
Externí odkaz:
https://doaj.org/article/8653776d94114edea55191f30c4446f9
Autor:
Maria I. Volkova, Alexey S. Kalpinskiy, Konstantin V. Menshikov, Lilia V. Gorbuleva, Alexander V. Sultanbaev, Olga I. Evsyukova, Varazdat R. Meltonian, Sergey V. Mishugin, Mikhail R. Maturov, Anna S. Olshanskaya, Dmitrii Iu. Shemetov, Tatyana A. Sannikova, Mariia V. Makhnutina, Marina A. Filipieva, Elena A. Gaijsina, Elena G. Ovchinnikova, Ovsep A. Mailian, Boris Ya. Alekseev, Vsevolod B. Matveev
Publikováno v:
Современная онкология, Vol 25, Iss 2, Pp 221-228 (2023)
Aim. To assess the safety and to analyze an influence of cabozantinib monotherapy toxicity on treatment efficacy in unselected Russian patients with metastatic renal cell carcinoma (mRCC). Materials and methods. Medical data of 92 patients with ve
Externí odkaz:
https://doaj.org/article/661c9556c8fd45debb7fe8c15b3a720b
Autor:
Goronkova, Olga, Novichkova, Galina, Salimova, Tatiana, Kalinina, Irina, Baidildina, Dina, Petrova, Ulyana, Antonova, Kristina, Sadovskaya, Maria, Suntsova, Elena, Evseev, Dmitry, Matveev, Victor, Venyov, Dmitry, Khachatryan, Lili, Litvinov, Dmitry, Pshonkin, Alexey, Ovsyannikova, Galina, Kotskaya, Natalia, Gobadze, Darina, Olshanskaya, Yulia, Popov, Alexander, Raykina, Elena, Mironenko, Olga, Voronin, Kirill, Purbueva, Bazarma, Boichenko, Elmira, Dinikina, Yulia, Guseynova, Evgeniya, Sherstnev, Dmitry, Kalinina, Elena, Mezentsev, Sergey, Streneva, Olga, Yudina, Natalia, Plaksina, Olga, Erega, Elena, Maschan, Michael, Maschan, Alexey
Publikováno v:
In Blood Advances April 2022
Autor:
A. D. Koltakova, A. M. Lila, O. G. Alekseeva, A. A. Fedenko, Y. V. Gridneva, A. S. Olshanskaya
Publikováno v:
Современная ревматология, Vol 16, Iss 5, Pp 46-52 (2022)
Objective: to describe musculoskeletal immune-mediated adverse events (iAEs) associated with the therapy of solid tumors with immune checkpoint inhibitors (ICIs, inhibitors of the PD-1/PD-L1 pathway).Patients and methods. 13 patients receiving ICIs t
Externí odkaz:
https://doaj.org/article/b651571d2d7d46de90e558bff186e959